CARLSBAD, Calif., July 12, 2018 /PRNewswire/ -- Progenitor Biologics®, LLC, the manufacturer and distributor of the revolutionary anti-aging skin care products, DefenAge® Skincare, is proud to announce that the breakthrough line has been named "Non-Surgical Innovator of the Year" by the prestigious The Aesthetic Channel's TAG! You're IT! Aesthetic Awards powered by Dermatology Times. DefenAge is the only skincare company, among all other winners, to receive the TAG! You're IT! Award in 2018.
"The TAG! You're IT! Award shines a spotlight on influencers and innovators in aesthetic medicine who are shaping the future of the industry," said Amy Ammon, Publisher of Dermatology Times, THE Aesthetic Guide, and The Aesthetic Channel.
DefenAge was recognized for its game-changing proprietary Age-Repair Defensins® technology, helping the brand to stand out among over two hundred submissions in twelve nominations that were vigorously reviewed by UBM and The Aesthetic Channel's editorial advisory board. The winner in each category was determined by eight judges, who are key thought leaders in medical aesthetics. The competitive category celebrates brands like DefenAge, who demonstrate an original approach to addressing aesthetic concerns.
"DefenAge redefined traditional skin care and especially anti-aging skin care, the way how skin 're-youthening' can be triggered," comments Progenitor Biologics' CEO, Nikolay Turovets, PhD. "Our team is extremely proud to be recognized by such a prestigious resource as The Aesthetic Channel."
Scientifically backed and clinically proven, DefenAge is dedicated to driving innovation to effectively address global signs of aging. The line's key ingredient, Age-Repair Defensins, is proven to reduce visible wrinkles and pore size, improve skin tone and evenness and decrease skin oiliness in just six weeks.
Defensins are a type of antimicrobial peptide that play an important role in the protection and treatment of skin cells by activating Lgr6+ stem cells, which are known to heal and repair the skin during wound healing. Because aging and wound healing share similar genetic and cellular pathways, researchers believe that stimulating these stem cells with the peptide may also effectively treat skin deterioration and damage from UV exposure, inflammation and oxidative stress—all harbingers of skin aging.
With its patent-pending peptides, the Age-Repair Defensins, DefenAge is the first of its kind to work via a natural mechanism of action with the body's stem cells to create beautiful new skin. DefenAge unlocks skin's potential to remain youthful with natural, scientifically-proven skincare that is simple, regenerative and effective.
About The Aesthetic Channel
The Aesthetic Channel (TAC) is a global source for events and media in aesthetic medicine and the authority for relevant, progressive and contemporary medical aesthetics, uniting annual, world-class events; three publications for US, European and Asian markets; and a unique practice development program offering provider certification. TAC and Dermatology Times are a part of UBM Medica, is one of the largest healthcare media and publishing companies in the United States that engage 3.5 million decision-makers covering the patient care spectrum.
DefenAge® Skincare is a technology-driven anti-aging skin care line, primarily distributed through the professional aesthetic market including dermatology and aesthetic surgery practices. The key ingredient, Age-Repair Defensins®, features a stand-alone natural target-specific mechanism of action. The technology is patent-pending, exclusively available in DefenAge and does not belong to the growth factor category. The Clinical Power Trio is clinical study tested, DefenAge's core skin care regimen that addresses visible signs of skin aging on a global scale. DefenAge products do not contain: animal- or human-originated ingredients, parabens, formaldehyde-releasing preservatives, sulfates, mineral oils, colorants, phthalates or BPA.
Products are available at www.DefenAge.com.
For more information, please visit www.DefenAge.com or connect with the company on: